Cas 1366067-97-1,3-tert-butoxycarbonylaminopropionic acid cyclohexyloxycarbonylmethyl ester

1366067-97-1

Post Buying Request

Basic information

Product Name: 3-tert-butoxycarbonylaminopropionic acid cyclohexyloxycarbonylmethyl ester
Synonyms:
CAS NO:1366067-97-1
Molecular Formula:
Molecular Weight: 329.393
EINECS: N/A
Product Categories: N/A
Mol File: 1366067-97-1.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-tert-butoxycarbonylaminopropionic acid cyclohexyloxycarbonylmethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 3-tert-butoxycarbonylaminopropionic acid cyclohexyloxycarbonylmethyl ester(1366067-97-1)
EPA Substance Registry System: 3-tert-butoxycarbonylaminopropionic acid cyclohexyloxycarbonylmethyl ester(1366067-97-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1366067-97-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1366067-97-1 Suppliers

Recommended suppliersmore

1366067-97-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1366067-97-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,6,0,6 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1366067-97:
(9*1)+(8*3)+(7*6)+(6*6)+(5*0)+(4*6)+(3*7)+(2*9)+(1*7)=181
181 % 10 = 1
So 1366067-97-1 is a valid CAS Registry Number.

1366067-97-1Upstream product

1366067-97-1Downstream Products

1366067-97-1Relevant articles and documents

PYRAZINE DERIVATIVES AS ENAC BLOCKERS

-

Paragraph 0252, (2014/05/07)

Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1366067-97-1